• Latest Posts

Major progress as Swedish scientists get brain tumors to self destruct

8 rare diseases selected for gene therapy trial portfolio

Scribe and Prevail to accelerate CRISPR-based genetic medicines for neurological and neuromuscular diseases

Exothera partners with Quantoom and launches DNA business unit

Global partners announce The Big Catch-up vaccination effort

20Med Therapeutics and Touchlight collaborating on novel vaccine delivery platform 

ADVERTISEMENT

RetinAI and Boehringer Ingelheim to use AI to develop treatment for geographic atrophy

BioNTech adds antibody-drug conjugates to cancer portfolio with potential $1.5B partnership deal

Sponsored by 3 Apr 2023

BIO-Europe Spring 2023: The Highlights

Opinion 24 Mar 2023

PAN-TB regimens to address growing TB drug resistance

OncoC4 and BioNTech partner in the commercialization of cancer drug candidate

ADVERTISEMENT